Peer Review History

Original SubmissionOctober 31, 2024
Decision Letter - Melissa Vazquez Hernandez, Editor

Dear Dr Bringaud,

Thank you for submitting your manuscript entitled "The glycosomal ATP-dependent phosphofructokinase of Trypanosoma brucei operates in the gluconeogenic direction in cellulo under in vivo-like conditions" for consideration as a Research Article by PLOS Biology.

Your manuscript has now been evaluated by the PLOS Biology editorial staff, as well as by an academic editor with relevant expertise, and I am writing to let you know that we would like to send your submission out for external peer review.

However, before we can send your manuscript to reviewers, we need you to complete your submission by providing the metadata that is required for full assessment. To this end, please login to Editorial Manager where you will find the paper in the 'Submissions Needing Revisions' folder on your homepage. Please click 'Revise Submission' from the Action Links and complete all additional questions in the submission questionnaire.

Once your full submission is complete, your paper will undergo a series of checks in preparation for peer review. After your manuscript has passed the checks it will be sent out for review. To provide the metadata for your submission, please Login to Editorial Manager (https://www.editorialmanager.com/pbiology) within two working days, i.e. by Nov 14 2024 11:59PM.

If your manuscript has been previously peer-reviewed at another journal, PLOS Biology is willing to work with those reviews in order to avoid re-starting the process. Submission of the previous reviews is entirely optional and our ability to use them effectively will depend on the willingness of the previous journal to confirm the content of the reports and share the reviewer identities. Please note that we reserve the right to invite additional reviewers if we consider that additional/independent reviewers are needed, although we aim to avoid this as far as possible. In our experience, working with previous reviews does save time.

If you would like us to consider previous reviewer reports, please edit your cover letter to let us know and include the name of the journal where the work was previously considered and the manuscript ID it was given. In addition, please upload a response to the reviews as a 'Prior Peer Review' file type, which should include the reports in full and a point-by-point reply detailing how you have or plan to address the reviewers' concerns.

During the process of completing your manuscript submission, you will be invited to opt-in to posting your pre-review manuscript as a bioRxiv preprint. Visit http://journals.plos.org/plosbiology/s/preprints for full details. If you consent to posting your current manuscript as a preprint, please upload a single Preprint PDF.

Feel free to email us at plosbiology@plos.org if you have any queries relating to your submission.

Kind regards,

Melissa

Melissa Vazquez Hernandez, Ph.D.

Associate Editor

PLOS Biology

mvazquezhernandez@plos.org

Revision 1
Decision Letter - Melissa Vazquez Hernandez, Editor

Dear Dr Bringaud,

Thank you for your patience while your manuscript "The glycosomal ATP-dependent phosphofructokinase of Trypanosoma brucei operates in the gluconeogenic direction in cellulo under in vivo-like conditions" went through peer-review at PLOS Biology. Your manuscript has now been evaluated by the PLOS Biology editors, an Academic Editor with relevant expertise, and by several independent reviewers.

As you will see in the reports, the reviewers are generally positive but have raised some concerns and provided suggestions for improvement. Reviewer #1 requests clarifications on experimental methods and the inclusion of missing statistical tests. Notably, it is unclear how many replicates were performed for each experiment. If the data represent repeats, please specify this in the text; however, if they are from a single replicate, additional experiments will be necessary to ensure robustness. Additionally, Reviewer #2 suggests incorporating dynamic models to evaluate various scenarios.

We expect to receive your revised manuscript within 2 months. Please email us (plosbiology@plos.org) if you have any questions or concerns, or would like to request an extension.

At this stage, your manuscript remains formally under active consideration at our journal; please notify us by email if you do not intend to submit a revision so that we withdraw the manuscript.

**IMPORTANT - SUBMITTING YOUR REVISION**

Your revisions should address the specific points made by each reviewer. Please submit the following files along with your revised manuscript:

1. A 'Response to Reviewers' file - this should detail your responses to the editorial requests, present a point-by-point response to all of the reviewers' comments, and indicate the changes made to the manuscript.

*NOTE: In your point-by-point response to the reviewers, please provide the full context of each review. Do not selectively quote paragraphs or sentences to reply to. The entire set of reviewer comments should be present in full and each specific point should be responded to individually.

You should also cite any additional relevant literature that has been published since the original submission and mention any additional citations in your response.

2. In addition to a clean copy of the manuscript, please also upload a 'track-changes' version of your manuscript that specifies the edits made. This should be uploaded as a "Revised Article with Changes Highlighted " file type.

*Resubmission Checklist*

When you are ready to resubmit your revised manuscript, please refer to this resubmission checklist: https://plos.io/Biology_Checklist

To submit a revised version of your manuscript, please go to https://www.editorialmanager.com/pbiology/ and log in as an Author. Click the link labelled 'Submissions Needing Revision' where you will find your submission record.

Please make sure to read the following important policies and guidelines while preparing your revision:

*Published Peer Review*

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. Please see here for more details:

https://blogs.plos.org/plos/2019/05/plos-journals-now-open-for-published-peer-review/

*PLOS Data Policy*

Please note that as a condition of publication PLOS' data policy (http://journals.plos.org/plosbiology/s/data-availability) requires that you make available all data used to draw the conclusions arrived at in your manuscript. If you have not already done so, you must include any data used in your manuscript either in appropriate repositories, within the body of the manuscript, or as supporting information (N.B. this includes any numerical values that were used to generate graphs, histograms etc.). For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5

*Blot and Gel Data Policy*

We require the original, uncropped and minimally adjusted images supporting all blot and gel results reported in an article's figures or Supporting Information files. We will require these files before a manuscript can be accepted so please prepare them now, if you have not already uploaded them. Please carefully read our guidelines for how to prepare and upload this data: https://journals.plos.org/plosbiology/s/figures#loc-blot-and-gel-reporting-requirements

*Protocols deposition*

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Thank you again for your submission to our journal. We hope that our editorial process has been constructive thus far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Melissa

Melissa Vazquez Hernandez, Ph.D.

Associate Editor

PLOS Biology

mvazquezhernandez@plos.org

----------------------------------------------------------------

REVIEWERS' COMMENTS:

----------------------------------------------------------------

Reviewer #1:

The Authors found that, using glycerol as a carbon source, T. brucei procyclic forms produce fructose 6-phosphate from fructose 1,6-bisphosphate using fructose 1,6-bisphosphatase, sedoheptulose 1,7-bisphosphatase, and ATP-dependent phosphofructokinase (PFK). The function of PFK in gluconeogenesis rather than in glycolysis is novel and attributed to the supramolecular organization of the pathway within glycosomes that allows metabolic channeling and produces ATP to maintain the ATP/ADP glycosomal balance. This is a thoughtfully considered study. Overall, this manuscript could advance the field, but some clarifications are needed.

1. Results, (line 168). The paragraph starts with the description of previous results, but it is not clear whether it continues with the description of those results, or it starts describing new results ("This was determined…": when, before or in this work?). This section needs a better description of Fig. 2 to explain how the conclusions were reached considering what the figure is showing. It is not clear to me where it is shown in Fig. 2 that 91% of F1,6BP were fully [13C]-enriched from [U-13C] glycerol, compared to 48% from [U-13C] proline. The meaning of the different arrows in the figure should be indicated. What are the other bands that are not due to PFK? The western blot needs some indication of the MW of the bands and the full blot should be presented in a supplementary figure. The same needs to be done with all other western blot analyses in the paper (Figs. 3A, 4A, 5C, 6C, 7A and 9H). In addition, when quantifications of western blot results are presented, the Authors should provide information about the number of western blots (n), and the statistical treatment of the data.

2. Why Fig. 3B does not show s.d.? Is it only one experiment? Fig. 3C shows error bars with no indication of what they are, the number of experiments (n) and the statistical test used to detect significant differences. Fig. 3D needs clarification regarding how the % enrichment is evident when seeing the figure.

3. Fig. 4A. The first arrow does not indicate any band. Where is the genetic evidence of SBPase KO?

4. Does Fig. 5E show the results of a single experiment?

5. Fig. 8 needs to indicate meaning of error bars, number of experiments (n).

6. Fig. 9I and 9J need to indicate meaning of error bars, number of experiments (n), significance and statistical test used to detect significant differences.

7. Lines 729-730 refer to something underlined and in italics. What figures shows that?

8. Line 875. Are there video-microscopy experiments?

— — —

Reviewer #2:

The article of Plazolles et al. is a rich depiction of contributions of various enzymes to gluconeogenesis in the procyclic form of Trypanosoma brucei. It breaks the dogma that ATP-dependent phosphofructokinases cannot be used in GNG and simultaneously provides new information on contributions of sedoheptulose bisphosphates and fructose bisphosphatase. The work includes an extraordinarily rich diversity of approaches including IC-MS based metabolic profiling and NMR analysis of metabolic end products. An impressive array of multiple gene knockouts/knockdowns, exploitation of marker free CRISPR-cas approches and novel routes to ascertain concentrations of ATP/ADP in cellulo.

There are just a couple of things I would like to have a clearer view upon.

Firstly it is the physiological role of PFK in GNG in trypanosomes. Could a sentence be added clarifying why glycerol is so much better than proline as a substrate for study (other than its better incorporation in H6P. It would be useful to explicitly outline why that is so.

Presumably proline would be the physiologically relevant substrate in tsetse fly (although might glycerol be more abundant than hitherto believed in tsetse, for instance via their fat bodies?).

Significant and effective models for glycolytic flux have been geenrated for bloodstream form trypanosomes. I appreciate that the current paper is not dependent upon modelling, but have the authors contemplated exploiting dynamic models of metabolism to ascertain a spectrum of scenarios around PFK working in either direction and consequences of titrating alternative starting substrated to probe any interplay between GNG vs glycolysis under different conditions?

Given the dogma-busting nature of the discovery of a PFK operating in GNG, some contemplation on whether this reflects the evolutionary history of the trypanosome's enzyme. If it evolved from a PPi dependent PFK is it possible it had an ancestral role in GNG, then its switch to use of ATP may have been possible due to the regulatory environment and possible concentration differentials within different sub-compartments (e.g. tunneling within an enzyme complex) that has permitted the change. What might expressing a PPi dependent PFK in trypanosomes do? (I'm not advocating for this experiment to be done here, just curious).

The paper is well presented, albeit with a number of imperfections in English language including (but not restricted to) the below

line 33: add comma after "through gluconeogenesis"

line 35: changed "showed" to "show"

Line 58: Remove "the" before "central carbon metabolism"

line 60: change to "tightly regulated allosterically"

line 79: remove "the" before "kidney"

Line 87: humans (with an "s")

line 102: "by analogy" better than "in analogy"

line 104: put comms around "for instance"

line 107: remove "the" before PCF

Fig 1 title, also remove "the" before PCF

line 139: add "the" before PPP

line 143: remove "the" before cofactor and add "the" before PPP

line 145: E4P (not EAP)

line 187: "was" not were fully enriched

line 305: remove "s" from differences

line 448: "in" not "into" glycosomes

line 544: remove "the" before procyclic

Revision 2

Attachments
Attachment
Submitted filename: Response to reviewers.pdf
Decision Letter - Melissa Vazquez Hernandez, Editor

Dear Frédéric,

Thank you for your patience while we considered your revised manuscript "The glycosomal ATP-dependent phosphofructokinase of Trypanosoma brucei operates in the gluconeogenic direction in cellulo under in vivo-like conditions" for publication as a Research Article at PLOS Biology. This revised version of your manuscript has been evaluated by the PLOS Biology editors, and the Academic Editor.

Based on our Academic Editor's assessment of your revision, we are likely to accept this manuscript for publication, provided you satisfactorily address the remaining editorial requests. Please make sure to address the following data and other policy-related requests.

a) We routinely suggest changes to titles to ensure maximum accessibility for a broad, non-specialist readership, and to ensure they reflect the contents of the paper. In this case, we would suggest a minor edit to the title, as follows. Please ensure you change both the manuscript file and the online submission system, as they need to match for final acceptance:

"The glycosomal ATP-dependent phosphofructokinase of Trypanosoma brucei operates in the gluconeogenic direction"

b) Please indicate what does the error bar indicate in Fig 8.

c) You may be aware of the PLOS Data Policy, which requires that all data be made available without restriction: http://journals.plos.org/plosbiology/s/data-availability. For more information, please also see this editorial: http://dx.doi.org/10.1371/journal.pbio.1001797

Please supply the numerical values either in the a supplementary file or as a permanent DOI’d deposition for the following figures:

Figure 2, 3BCD, 4BC, 5DE, 7B, 8, 9CDIJ, S1

NOTE: the numerical data provided should include all replicates AND the way in which the plotted mean and errors were derived (it should not present only the mean/average values).

d) Please cite the location of the data clearly in all relevant main and supplementary Figure legends, e.g. “The data underlying this Figure can be found in S1 Data” or “The data underlying this Figure can be found in https://doi.org/10.5281/zenodo.XXXXX”

e) Please ensure that you are using best practice for statistical reporting and data presentation. These are our guidelines https://journals.plos.org/plosbiology/s/best-practices-in-research-reporting#loc-statistical-reporting and a useful resource on data presentation https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1002128

- If you are reporting experiments where n ≤ 5, please plot each individual data point.

f) We require the original, uncropped and minimally adjusted images supporting all blot and gel results reported in the Figures 1B, 2, 3A, 4A, 5BC, 6BC, 7A, 9H, S2A

We will require these files before a manuscript can be accepted so please prepare and upload them now. Please carefully read our guidelines for how to prepare and upload this data: https://journals.plos.org/plosbiology/s/figures#loc-blot-and-gel-reporting-requirements

g) Please ensure that your Data Statement in the submission system accurately describes where your data can be found and is in final format, as it will be published as written there.

h) Per journal policy, if you have generated any custom code during the course of this investigation, please make it available without restrictions upon publication. Please ensure that the code is sufficiently well documented and reusable, and that your Data Statement in the Editorial Manager submission system accurately describes where your code can be found.

Please note that we cannot accept sole deposition of code in GitHub, as this could be changed after publication. However, you can archive this version of your publicly available GitHub code to Zenodo. Once you do this, it will generate a DOI number, which you will need to provide in the Data Accessibility Statement (you are welcome to also provide the GitHub access information). See the process for doing this here: https://docs.github.com/en/repositories/archiving-a-github-repository/referencing-and-citing-content

As you address these items, please take this last chance to review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the cover letter that accompanies your revised manuscript.

In addition to these revisions, you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests shortly.

We expect to receive your revised manuscript within two weeks.

To submit your revision, please go to https://www.editorialmanager.com/pbiology/ and log in as an Author. Click the link labelled 'Submissions Needing Revision' to find your submission record. Your revised submission must include the following:

- a cover letter that should detail your responses to any editorial requests, if applicable, and whether changes have been made to the reference list

- a Response to Reviewers file that provides a detailed response to the reviewers' comments (if applicable, if not applicable please do not delete your existing 'Response to Reviewers' file.)

- a track-changes file indicating any changes that you have made to the manuscript.

NOTE: If Supporting Information files are included with your article, note that these are not copyedited and will be published as they are submitted. Please ensure that these files are legible and of high quality (at least 300 dpi) in an easily accessible file format. For this reason, please be aware that any references listed in an SI file will not be indexed. For more information, see our Supporting Information guidelines:

https://journals.plos.org/plosbiology/s/supporting-information

*Published Peer Review History*

Please note that you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. Please see here for more details:

https://plos.org/published-peer-review-history/

*Press*

Should you, your institution's press office or the journal office choose to press release your paper, please ensure you have opted out of Early Article Posting on the submission form. We ask that you notify us as soon as possible if you or your institution is planning to press release the article.

*Protocols deposition*

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Please do not hesitate to contact me should you have any questions.

Sincerely,

Melissa

Melissa Vazquez Hernandez, Ph.D.

Associate Editor

mvazquezhernandez@plos.org

PLOS Biology

Revision 3

Attachments
Attachment
Submitted filename: Response to Editor-v2.pdf
Decision Letter - Melissa Vazquez Hernandez, Editor

Dear Frédéric,

I would like to apologize for not answering your e-mail about the extension to submit the metadata, I somehow missed to get back to you.

Thank you for the submission of your revised Research Article "The glycosomal ATP-dependent phosphofructokinase of Trypanosoma brucei also operates in the gluconeogenic direction" for publication in PLOS Biology. On behalf of my colleagues and the Academic Editor, Tania de Koning-Ward, I am pleased to say that we can in principle accept your manuscript for publication, provided you address any remaining formatting and reporting issues. These will be detailed in an email you should receive within 2-3 business days from our colleagues in the journal operations team; no action is required from you until then. Please note that we will not be able to formally accept your manuscript and schedule it for publication until you have completed any requested changes.

IMPORTANT: Many thanks for providing the images for all gels and blots. However, we require that these are the images of the full gels and not cropped or modified in any way. I am afraid that most of the images are still cropped. I have asked my colleagues to include this request alongside their own.

Please take a minute to log into Editorial Manager at http://www.editorialmanager.com/pbiology/, click the "Update My Information" link at the top of the page, and update your user information to ensure an efficient production process.

PRESS

We frequently collaborate with press offices. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximise its impact. If the press office is planning to promote your findings, we would be grateful if they could coordinate with biologypress@plos.org. If you have previously opted in to the early version process, we ask that you notify us immediately of any press plans so that we may opt out on your behalf.

We also ask that you take this opportunity to read our Embargo Policy regarding the discussion, promotion and media coverage of work that is yet to be published by PLOS. As your manuscript is not yet published, it is bound by the conditions of our Embargo Policy. Please be aware that this policy is in place both to ensure that any press coverage of your article is fully substantiated and to provide a direct link between such coverage and the published work. For full details of our Embargo Policy, please visit http://www.plos.org/about/media-inquiries/embargo-policy/.

Thank you again for choosing PLOS Biology for publication and supporting Open Access publishing. We look forward to publishing your study. 

Sincerely, 

Melissa

Melissa Vazquez Hernandez, Ph.D., Ph.D.

Associate Editor

PLOS Biology

mvazquezhernandez@plos.org

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .